$XXII on NYSE AMERICAN
May 07, 2020
22nd Century Group Reports First Quarter 2020 Financial Results
April 30, 2020
22nd Century Group Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials
April 28, 2020
22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020
April 17, 2020
FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP Application
April 08, 2020
22nd Century Group to Hold Virtual Annual Meeting of Stockholders
March 12, 2020
22nd Century Group, Inc. Files 2019 Annual Report
March 11, 2020
22nd Century Announces Important New Achievements with KeyGene
March 10, 2020
22nd Century Group Adds to Leadership Team
March 04, 2020
CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking
March 04, 2020
Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use
February 18, 2020
FDA Scientific Advisory Committee Discusses 22nd Century Group’s Reduced Nicotine Cigarettes
February 11, 2020
22nd Century Group’s FDA Advisory Committee Meeting for Reduced Nicotine Content Cigarettes Brings New Standard for the Tobacco Industry
January 13, 2020
22nd Century Group Appoints New Director and New Chairman
December 23, 2019
22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee
December 17, 2019
FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol Cigarettes
December 13, 2019
22nd Century Group Announces Management Changes
December 03, 2019
22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc.
November 21, 2019
22nd Century Group Comments on Delay of Reduced Nicotine Rule for Cigarettes
November 07, 2019
22nd Century Group Files 2019 Third Quarter Report
November 04, 2019
22nd Century Group Announces Webcast to Provide Business Update
August 07, 2019
22nd Century Group Files 2019 Second Quarter Report
August 05, 2019
22nd Century Group Appoints Cliff Fleet Chief Executive Officer
August 02, 2019
22nd Century Group Announces Conference Call to Provide Business Update
July 26, 2019
22nd Century Group CEO to Step Down
July 19, 2019
FDA Accepts and Files 22nd Century Group’s Modified Risk Tobacco Product Application for VLN™ Cigarettes
- No Recent Filings Found.
